Showing results (321-330 of 408) with videos related to
Sort By:
Pageof 41
The Journal of Clinical Investigation|August 28, 2020
Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infectionHongzhao Li, Robert W Omange, Binhua Liang, et al.JCI Insight|March 9, 2018
Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding siteHao D Cheng, Sebastian K Grimm, Morgan Sa Gilman, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Engineering Sustained-Release Broadly Neutralizing Antibody FormulationsCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.Nature|November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysDan H Barouch, James B Whitney, Brian Moldt, et al.Nature|April 10, 2015
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Marina Caskey, Florian Klein, Julio C C Lorenzi, et al.Nature Medicine|September 12, 2024
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trialBoris Julg, Victoria E K Walker-Sperling, Kshitij Wagh, et al.The Lancet. HIV|May 1, 2024
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trialIan Frank, Shuying S Li, Nicole Grunenberg, et al.Biorxiv : the Preprint Server for Biology|February 6, 2026
B Lymphocyte Protein Factories produced by Hematopoietic Stem Cell Gene EditingHarald Hartweger, Chiara Ruprecht, Kai-Hui Yao, et al.Nature Medicine|July 7, 2026
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trialDeborah A Theodore, Bryan T Mayer, Charlotte-Paige Rolle, et al.The Journal of Infectious Diseases|November 9, 2022
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a StudyDaniel J Stieh, Dan H Barouch, Christy Comeaux, et al.Pageof 41